chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Activated partial thromboplastin time, Disorientation, Dizziness, Dyspnoea, Full blood count
Clinical narrative: Odd bruising on the upper part of  back. Both sides of spine.; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP7534) via an unspecified route of administration in the left arm on 06Apr2021 at 16:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. The patient did not have any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: EL9266) via an unspecified route of administration in the left arm on 09Mar2021 at 17:00 (at the age of 40-years-old) as a single dose for Covid-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced odd bruising on the upper part of back and on both sides of spine. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event odd bruising on the upper part of back and on both sides of spine was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Gastrointestinal disorder, International normalised ratio, Prothrombin time, Urinary tract discomfort, Vision blurred
Clinical narrative: Odd bruising on the upper part of  back. Both sides of spine.; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP7534) via an unspecified route of administration in the left arm on 06Apr2021 at 16:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. The patient did not have any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: EL9266) via an unspecified route of administration in the left arm on 09Mar2021 at 17:00 (at the age of 40-years-old) as a single dose for Covid-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced odd bruising on the upper part of back and on both sides of spine. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event odd bruising on the upper part of back and on both sides of spine was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Contusion
Clinical narrative: Odd bruising on the upper part of  back. Both sides of spine.; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP7534) via an unspecified route of administration in the left arm on 06Apr2021 at 16:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. The patient did not have any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: EL9266) via an unspecified route of administration in the left arm on 09Mar2021 at 17:00 (at the age of 40-years-old) as a single dose for Covid-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced odd bruising on the upper part of back and on both sides of spine. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event odd bruising on the upper part of back and on both sides of spine was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: sores in mouth, tongue and throat; chills; skin rash; blisters on back; skin rash on face and forehead that feels like burning and itchy; skin rash on face and forehead that feels like burning and itchy; sores in mouth, tongue and throat; sores in mouth, tongue and throat; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0150) via an unspecified route of administration in the arm left on 03Apr2021 at 8:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol. Concomitant medications included vitamins (MANUFACTURER UNKNOWN) indicated for unknown indication. The patient had a history of drug allergy to Keflex, penicillin and Bactrim. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 18:00, the patient experienced skin rash and blisters on back, skin rash on face and forehead that feels like burning and itchy, skin rash on arms, sores in mouth, tongue and throat, inside of lower lip swollen and chills. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. The clinical outcome of the events chills was passed and skin rash and blisters on back, skin rash on face and forehead that felt like burning and itchy, sores in mouth, tongue and throat, inside of lower lip swollen was ongoing.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blister, Chills, Glossodynia, Oropharyngeal pain, Pruritus
Clinical narrative: sores in mouth, tongue and throat; chills; skin rash; blisters on back; skin rash on face and forehead that feels like burning and itchy; skin rash on face and forehead that feels like burning and itchy; sores in mouth, tongue and throat; sores in mouth, tongue and throat; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0150) via an unspecified route of administration in the arm left on 03Apr2021 at 8:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol. Concomitant medications included vitamins (MANUFACTURER UNKNOWN) indicated for unknown indication. The patient had a history of drug allergy to Keflex, penicillin and Bactrim. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 18:00, the patient experienced skin rash and blisters on back, skin rash on face and forehead that feels like burning and itchy, skin rash on arms, sores in mouth, tongue and throat, inside of lower lip swollen and chills. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. The clinical outcome of the events chills was passed and skin rash and blisters on back, skin rash on face and forehead that felt like burning and itchy, sores in mouth, tongue and throat, inside of lower lip swollen was ongoing.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Rash pruritic, Stomatitis
Clinical narrative: sores in mouth, tongue and throat; chills; skin rash; blisters on back; skin rash on face and forehead that feels like burning and itchy; skin rash on face and forehead that feels like burning and itchy; sores in mouth, tongue and throat; sores in mouth, tongue and throat; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0150) via an unspecified route of administration in the arm left on 03Apr2021 at 8:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol. Concomitant medications included vitamins (MANUFACTURER UNKNOWN) indicated for unknown indication. The patient had a history of drug allergy to Keflex, penicillin and Bactrim. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 18:00, the patient experienced skin rash and blisters on back, skin rash on face and forehead that feels like burning and itchy, skin rash on arms, sores in mouth, tongue and throat, inside of lower lip swollen and chills. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. The clinical outcome of the events chills was passed and skin rash and blisters on back, skin rash on face and forehead that felt like burning and itchy, sores in mouth, tongue and throat, inside of lower lip swollen was ongoing.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Dyspnoea, Palpitations, Parosmia, Tachycardia
Clinical narrative: Tachycardia; Palpitations; Breathlessness; This is a spontaneous report from a contactable other health care professional. A 35-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 08Apr2021 13:30 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE) taken for an unspecified indication, start and stop date were not reported. The patient experienced tachycardia, palpitations, breathlessness on 09Apr2021 with outcome of not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Taste disorder
Clinical narrative: Tachycardia; Palpitations; Breathlessness; This is a spontaneous report from a contactable other health care professional. A 35-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 08Apr2021 13:30 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE) taken for an unspecified indication, start and stop date were not reported. The patient experienced tachycardia, palpitations, breathlessness on 09Apr2021 with outcome of not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Palpitations, Tachycardia
Clinical narrative: Tachycardia; Palpitations; Breathlessness; This is a spontaneous report from a contactable other health care professional. A 35-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 08Apr2021 13:30 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE) taken for an unspecified indication, start and stop date were not reported. The patient experienced tachycardia, palpitations, breathlessness on 09Apr2021 with outcome of not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Death, Hypotension, Syncope, Vomiting
Clinical narrative: Complained of nausea, vomiting, weakness one hour after injection followed by syncopal episode and severe back pain.  Became hypotensive and tachycardic in ER followed by cardiorespiratory arrest.  Autopsy performed next day showed ruptured abdominal aortic aneurysm with large retroperitoneal hematoma. Cause of death was massive retroperitoneal hemorrhage due to ruptured abdominal aortic aneurysm due to hypertensive and atherosclerotic cardiovascular disease.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Aortic aneurysm, Aortic aneurysm rupture, Arteriosclerosis, Asthenia, Autopsy
Clinical narrative: Complained of nausea, vomiting, weakness one hour after injection followed by syncopal episode and severe back pain.  Became hypotensive and tachycardic in ER followed by cardiorespiratory arrest.  Autopsy performed next day showed ruptured abdominal aortic aneurysm with large retroperitoneal hematoma. Cause of death was massive retroperitoneal hemorrhage due to ruptured abdominal aortic aneurysm due to hypertensive and atherosclerotic cardiovascular disease.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Cardio-respiratory arrest, Death, Hypertensive heart disease, Hypotension
Clinical narrative: Complained of nausea, vomiting, weakness one hour after injection followed by syncopal episode and severe back pain.  Became hypotensive and tachycardic in ER followed by cardiorespiratory arrest.  Autopsy performed next day showed ruptured abdominal aortic aneurysm with large retroperitoneal hematoma. Cause of death was massive retroperitoneal hemorrhage due to ruptured abdominal aortic aneurysm due to hypertensive and atherosclerotic cardiovascular disease.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Retroperitoneal haematoma, Syncope, Tachycardia, Vomiting
Clinical narrative: Complained of nausea, vomiting, weakness one hour after injection followed by syncopal episode and severe back pain.  Became hypotensive and tachycardic in ER followed by cardiorespiratory arrest.  Autopsy performed next day showed ruptured abdominal aortic aneurysm with large retroperitoneal hematoma. Cause of death was massive retroperitoneal hemorrhage due to ruptured abdominal aortic aneurysm due to hypertensive and atherosclerotic cardiovascular disease.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness
Clinical narrative: dizziness; lightheartedness; This is a spontaneous report from a non-contactable pharmacist. A 62-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8733), via an intramuscular route of administration in the right arm on 19Apr2021 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included elevated BP(blood pressure). Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8727) via an intramuscular route of administration in the left arm on 29Mar2021 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021, the patient experienced  dizziness and lightheartedness. It was reported that the patient felt elevated BP prior to vaccination and patient left RUHS 30 minutes after vaccine administration. The patient underwent lab tests of vital signs pre-vaccine on 19Apr2021 which included BP of 166/77, HR(heart rate) of 68, O2(oxygen saturation) of  96% and she was given 8oz of water. The patient underwent vitals signs again 10 minutes later which was found to be a BP of 138/66, HR of 66, O2 of 96% and BG(blood glucose) of 132. The patient did not receive any treatment for the reported events. The clinical outcomes of the events dizziness and lightheartedness was recovered on an unknown date in 2021.    No follow-up attempts are possible. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood glucose, Blood pressure measurement, Dizziness, Heart rate, Oxygen saturation
Clinical narrative: dizziness; lightheartedness; This is a spontaneous report from a non-contactable pharmacist. A 62-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8733), via an intramuscular route of administration in the right arm on 19Apr2021 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included elevated BP(blood pressure). Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8727) via an intramuscular route of administration in the left arm on 29Mar2021 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021, the patient experienced  dizziness and lightheartedness. It was reported that the patient felt elevated BP prior to vaccination and patient left RUHS 30 minutes after vaccine administration. The patient underwent lab tests of vital signs pre-vaccine on 19Apr2021 which included BP of 166/77, HR(heart rate) of 68, O2(oxygen saturation) of  96% and she was given 8oz of water. The patient underwent vitals signs again 10 minutes later which was found to be a BP of 138/66, HR of 66, O2 of 96% and BG(blood glucose) of 132. The patient did not receive any treatment for the reported events. The clinical outcomes of the events dizziness and lightheartedness was recovered on an unknown date in 2021.    No follow-up attempts are possible. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations
Clinical narrative: dizziness; lightheartedness; This is a spontaneous report from a non-contactable pharmacist. A 62-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8733), via an intramuscular route of administration in the right arm on 19Apr2021 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included elevated BP(blood pressure). Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8727) via an intramuscular route of administration in the left arm on 29Mar2021 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021, the patient experienced  dizziness and lightheartedness. It was reported that the patient felt elevated BP prior to vaccination and patient left RUHS 30 minutes after vaccine administration. The patient underwent lab tests of vital signs pre-vaccine on 19Apr2021 which included BP of 166/77, HR(heart rate) of 68, O2(oxygen saturation) of  96% and she was given 8oz of water. The patient underwent vitals signs again 10 minutes later which was found to be a BP of 138/66, HR of 66, O2 of 96% and BG(blood glucose) of 132. The patient did not receive any treatment for the reported events. The clinical outcomes of the events dizziness and lightheartedness was recovered on an unknown date in 2021.    No follow-up attempts are possible. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site pruritus, Injection site warmth
Clinical narrative: Arm began itching at injection site; Arm began itching at injection site, while scratching, noticed warmth to touch and a hard knot like area at injection site.; Arm began itching at injection site, while scratching, noticed warmth to touch and a hard knot like area at injection site.; Arm began itching at injection site, while scratching, noticed warmth to touch and a hard knot like area at injection site.  Injection site looked red and knot is visibly noticeable; This is a spontaneous report from a contactable other healthcare professional, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via intramuscular route of administration in the left arm on 29Apr2021 at 11:15 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma (reported as history of Asthma-contolled). The patient did not have allergy to any medications, food, or other products. The patients past drug was reported as no. Concomitant medications taken within two weeks prior to vaccination included Prenatal vitamin from unknown date for unknown indication. The patient had received other vaccines within four weeks prior to the vaccination, which included measles vaccine, mumps vaccine, rubella vaccine (MMR) on 14Apr2021 and hepatitis b vaccine (HEPATITIS B) on 14Apr2021, both for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07May2021 at 13:15, the patients arm began itching at injection site, while scratching, she noticed warmth to touch and a hard knot like area at injection site. Injection site looked red and knot was visibly noticeable. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events arm began itching at injection site, while scratching, noticed warmth to touch and a hard knot like area at injection site, injection site looked red and knot was visibly noticeable was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site pruritus, Injection site warmth, Vaccination site erythema, Vaccination site nodule
Clinical narrative: Arm began itching at injection site; Arm began itching at injection site, while scratching, noticed warmth to touch and a hard knot like area at injection site.; Arm began itching at injection site, while scratching, noticed warmth to touch and a hard knot like area at injection site.; Arm began itching at injection site, while scratching, noticed warmth to touch and a hard knot like area at injection site.  Injection site looked red and knot is visibly noticeable; This is a spontaneous report from a contactable other healthcare professional, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via intramuscular route of administration in the left arm on 29Apr2021 at 11:15 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma (reported as history of Asthma-contolled). The patient did not have allergy to any medications, food, or other products. The patients past drug was reported as no. Concomitant medications taken within two weeks prior to vaccination included Prenatal vitamin from unknown date for unknown indication. The patient had received other vaccines within four weeks prior to the vaccination, which included measles vaccine, mumps vaccine, rubella vaccine (MMR) on 14Apr2021 and hepatitis b vaccine (HEPATITIS B) on 14Apr2021, both for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07May2021 at 13:15, the patients arm began itching at injection site, while scratching, she noticed warmth to touch and a hard knot like area at injection site. Injection site looked red and knot was visibly noticeable. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events arm began itching at injection site, while scratching, noticed warmth to touch and a hard knot like area at injection site, injection site looked red and knot was visibly noticeable was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lip swelling, Rash, Rash pruritic, Swelling face
Clinical narrative: Lip swelling; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03May2021 at 15:30, (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route on an unknown date as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07May2021 at 00:00, the patient experienced lip swelling and worried what to do. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. The clinical outcome of lip swelling was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lip swelling
Clinical narrative: Lip swelling; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03May2021 at 15:30, (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route on an unknown date as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07May2021 at 00:00, the patient experienced lip swelling and worried what to do. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. The clinical outcome of lip swelling was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Left arm and shoulder pain and weakness.  Diagnosis of left brachial plexopathy confirmed by EMG/NCS.  Treated with prednisone, gabapentin and physical therapy.  At evaluation six weeks after onset weakness resolved and pain manageable with medications.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Brachial plexopathy, Electromyogram abnormal, Magnetic resonance imaging joint, Magnetic resonance imaging neck, Muscular weakness
Clinical narrative: Left arm and shoulder pain and weakness.  Diagnosis of left brachial plexopathy confirmed by EMG/NCS.  Treated with prednisone, gabapentin and physical therapy.  At evaluation six weeks after onset weakness resolved and pain manageable with medications.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nerve conduction studies abnormal
Clinical narrative: Left arm and shoulder pain and weakness.  Diagnosis of left brachial plexopathy confirmed by EMG/NCS.  Treated with prednisone, gabapentin and physical therapy.  At evaluation six weeks after onset weakness resolved and pain manageable with medications.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Epstein-Barr virus test, Fatigue, Grip strength decreased, Headache
Clinical narrative: (Whole body tremors /fasiculations, , urinary issues due to tremors, fatigue and body heaviness. Headaches, brain fog, muscle pain, joint pain
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging, Muscle spasms, Muscular weakness, Myalgia, SARS-CoV-2 test
Clinical narrative: (Whole body tremors /fasiculations, , urinary issues due to tremors, fatigue and body heaviness. Headaches, brain fog, muscle pain, joint pain
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test negative, Treponema test negative, Urine analysis
Clinical narrative: (Whole body tremors /fasiculations, , urinary issues due to tremors, fatigue and body heaviness. Headaches, brain fog, muscle pain, joint pain
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cluster headache, Confusional state, Dizziness, Drug hypersensitivity, Endometriosis
Clinical narrative: (Whole body tremors /fasiculations, , urinary issues due to tremors, fatigue and body heaviness. Headaches, brain fog, muscle pain, joint pain
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Mobility decreased, Muscular weakness
Clinical narrative: (Whole body tremors /fasiculations, , urinary issues due to tremors, fatigue and body heaviness. Headaches, brain fog, muscle pain, joint pain
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myalgia, Nausea, Ovarian cyst ruptured, SARS-CoV-2 test
Clinical narrative: (Whole body tremors /fasiculations, , urinary issues due to tremors, fatigue and body heaviness. Headaches, brain fog, muscle pain, joint pain
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anti-cyclic citrullinated peptide antibody negative, Antinuclear antibody positive, Arthralgia, Blood creatine phosphokinase normal, Blood thyroid stimulating hormone
Clinical narrative: (Whole body tremors /fasiculations, , urinary issues due to tremors, fatigue and body heaviness. Headaches, brain fog, muscle pain, joint pain
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: C-reactive protein normal, Discomfort, Fatigue, Feeling abnormal, Full blood count normal
Clinical narrative: (Whole body tremors /fasiculations, , urinary issues due to tremors, fatigue and body heaviness. Headaches, brain fog, muscle pain, joint pain
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: HLA-B*27 assay, Human chorionic gonadotropin negative, Magnetic resonance imaging head normal, Metabolic function test, Muscle contractions involuntary
Clinical narrative: (Whole body tremors /fasiculations, , urinary issues due to tremors, fatigue and body heaviness. Headaches, brain fog, muscle pain, joint pain
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myalgia, Red blood cell sedimentation rate normal, SARS-CoV-2 test negative, Thyroxine normal, Tremor
Clinical narrative: (Whole body tremors /fasiculations, , urinary issues due to tremors, fatigue and body heaviness. Headaches, brain fog, muscle pain, joint pain
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Urinary tract disorder, Vitamin D decreased
Clinical narrative: (Whole body tremors /fasiculations, , urinary issues due to tremors, fatigue and body heaviness. Headaches, brain fog, muscle pain, joint pain
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Chills, Decreased appetite, Fatigue, Gait inability
Clinical narrative: Per patient:  About an hour after the vaccination, he started to experience chills and a fever of 101degrees.  An elevated temperature of 99 degrees persisted for 2 and 1/2 weeks afterwards.  He reached out to his primary physician on 3/23/21 or 3/24/21.  He experienced exhaustion, loss of appetite, and insomnia for about 10 days.   He experienced inflammation of both knees, which to this day has not fully resolved, along with a sensation of pins/needles.   On 4/6/21 he was rushed to the ER with chest pain (thought he was experiencing a heart attack), but was diagnosed with severe anxiety, stress, exhaustion, and elevated blood pressure.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Immediate post-injection reaction, Impaired work ability, Insomnia, Joint swelling, Pyrexia
Clinical narrative: Per patient:  About an hour after the vaccination, he started to experience chills and a fever of 101degrees.  An elevated temperature of 99 degrees persisted for 2 and 1/2 weeks afterwards.  He reached out to his primary physician on 3/23/21 or 3/24/21.  He experienced exhaustion, loss of appetite, and insomnia for about 10 days.   He experienced inflammation of both knees, which to this day has not fully resolved, along with a sensation of pins/needles.   On 4/6/21 he was rushed to the ER with chest pain (thought he was experiencing a heart attack), but was diagnosed with severe anxiety, stress, exhaustion, and elevated blood pressure.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Blood pressure increased, Chest pain, Chills, Decreased appetite
Clinical narrative: Per patient:  About an hour after the vaccination, he started to experience chills and a fever of 101degrees.  An elevated temperature of 99 degrees persisted for 2 and 1/2 weeks afterwards.  He reached out to his primary physician on 3/23/21 or 3/24/21.  He experienced exhaustion, loss of appetite, and insomnia for about 10 days.   He experienced inflammation of both knees, which to this day has not fully resolved, along with a sensation of pins/needles.   On 4/6/21 he was rushed to the ER with chest pain (thought he was experiencing a heart attack), but was diagnosed with severe anxiety, stress, exhaustion, and elevated blood pressure.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Inflammation, Insomnia, Joint swelling, Paraesthesia
Clinical narrative: Per patient:  About an hour after the vaccination, he started to experience chills and a fever of 101degrees.  An elevated temperature of 99 degrees persisted for 2 and 1/2 weeks afterwards.  He reached out to his primary physician on 3/23/21 or 3/24/21.  He experienced exhaustion, loss of appetite, and insomnia for about 10 days.   He experienced inflammation of both knees, which to this day has not fully resolved, along with a sensation of pins/needles.   On 4/6/21 he was rushed to the ER with chest pain (thought he was experiencing a heart attack), but was diagnosed with severe anxiety, stress, exhaustion, and elevated blood pressure.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Stress
Clinical narrative: Per patient:  About an hour after the vaccination, he started to experience chills and a fever of 101degrees.  An elevated temperature of 99 degrees persisted for 2 and 1/2 weeks afterwards.  He reached out to his primary physician on 3/23/21 or 3/24/21.  He experienced exhaustion, loss of appetite, and insomnia for about 10 days.   He experienced inflammation of both knees, which to this day has not fully resolved, along with a sensation of pins/needles.   On 4/6/21 he was rushed to the ER with chest pain (thought he was experiencing a heart attack), but was diagnosed with severe anxiety, stress, exhaustion, and elevated blood pressure.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Burning sensation, Neuralgia, Pain, Pain in extremity, Pruritus
Clinical narrative: borderline paralyzed in his legs;; tingling in his hands and feet; extreme fatigue in arms and legs-; pins and needles in his feet; heart rate gets very fast from just standing up; His vision got blurry; sparks and burning feeling in his arms and legs; general mental fog, confusion, problems with depth perception and mental strain to remember; had nerve pain; a mild headache; After the first dose he was not feeling great; This is a spontaneous report from a contactable consumer or other non hcp. A 32-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0196, Expiration date was not reported), dose 1 via an unspecified route of administration on 12Jun2021 10:00 (age at vaccination 32 years) as dose 1, single for covid-19 immunisation. Medical history included guillain barre syndrome. There were no concomitant medications. On an unspecified date the patient experienced borderline paralyzed in his legs, tingling in his hands and feet, extreme fatigue in arms and legs, pins and needles in his feet, heart rate gets very fast from just standing up, his vision got blurry, sparks and burning feeling in his arms and legs, general mental fog, confusion, problems with depth perception and mental strain to remember, After the first dose he was not feeling great, had nerve pain, a mild headache. He has started nothing new, and he doesn't take anything not even take Advil for a headache. It showed reflex in knees and elbows, they don't work anymore. It was the same test they do for guillain barre syndrome. His primary care did blood work done and reflex tests and told him his reflexes were not good and they always have been. His blood pressure was high and had never been before. The caller states he had blood work done before and there were no issues, all numbers were good. After the vaccine things were not. He does not have the results in front of him but knows that he has high calcium which they say may be due to dehydration, but he is drinking a ton of water. Also, he has high blood pressure and never did until this vaccine. The patient underwent lab tests and procedures which included blood pressure measurement was high, heart rate was heart rate gets very fast from just standing up, nerve conduction studies was unknown, reflex test was unknown. The outcome of events was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202100929968 similar report from same reporter
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood test, Burning sensation, Fatigue, Feeling abnormal, Guillain-Barre syndrome
Clinical narrative: borderline paralyzed in his legs;; tingling in his hands and feet; extreme fatigue in arms and legs-; pins and needles in his feet; heart rate gets very fast from just standing up; His vision got blurry; sparks and burning feeling in his arms and legs; general mental fog, confusion, problems with depth perception and mental strain to remember; had nerve pain; a mild headache; After the first dose he was not feeling great; This is a spontaneous report from a contactable consumer or other non hcp. A 32-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0196, Expiration date was not reported), dose 1 via an unspecified route of administration on 12Jun2021 10:00 (age at vaccination 32 years) as dose 1, single for covid-19 immunisation. Medical history included guillain barre syndrome. There were no concomitant medications. On an unspecified date the patient experienced borderline paralyzed in his legs, tingling in his hands and feet, extreme fatigue in arms and legs, pins and needles in his feet, heart rate gets very fast from just standing up, his vision got blurry, sparks and burning feeling in his arms and legs, general mental fog, confusion, problems with depth perception and mental strain to remember, After the first dose he was not feeling great, had nerve pain, a mild headache. He has started nothing new, and he doesn't take anything not even take Advil for a headache. It showed reflex in knees and elbows, they don't work anymore. It was the same test they do for guillain barre syndrome. His primary care did blood work done and reflex tests and told him his reflexes were not good and they always have been. His blood pressure was high and had never been before. The caller states he had blood work done before and there were no issues, all numbers were good. After the vaccine things were not. He does not have the results in front of him but knows that he has high calcium which they say may be due to dehydration, but he is drinking a ton of water. Also, he has high blood pressure and never did until this vaccine. The patient underwent lab tests and procedures which included blood pressure measurement was high, heart rate was heart rate gets very fast from just standing up, nerve conduction studies was unknown, reflex test was unknown. The outcome of events was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202100929968 similar report from same reporter
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Headache, Heart rate, Neuralgia, Paraesthesia, Reflex test
Clinical narrative: borderline paralyzed in his legs;; tingling in his hands and feet; extreme fatigue in arms and legs-; pins and needles in his feet; heart rate gets very fast from just standing up; His vision got blurry; sparks and burning feeling in his arms and legs; general mental fog, confusion, problems with depth perception and mental strain to remember; had nerve pain; a mild headache; After the first dose he was not feeling great; This is a spontaneous report from a contactable consumer or other non hcp. A 32-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0196, Expiration date was not reported), dose 1 via an unspecified route of administration on 12Jun2021 10:00 (age at vaccination 32 years) as dose 1, single for covid-19 immunisation. Medical history included guillain barre syndrome. There were no concomitant medications. On an unspecified date the patient experienced borderline paralyzed in his legs, tingling in his hands and feet, extreme fatigue in arms and legs, pins and needles in his feet, heart rate gets very fast from just standing up, his vision got blurry, sparks and burning feeling in his arms and legs, general mental fog, confusion, problems with depth perception and mental strain to remember, After the first dose he was not feeling great, had nerve pain, a mild headache. He has started nothing new, and he doesn't take anything not even take Advil for a headache. It showed reflex in knees and elbows, they don't work anymore. It was the same test they do for guillain barre syndrome. His primary care did blood work done and reflex tests and told him his reflexes were not good and they always have been. His blood pressure was high and had never been before. The caller states he had blood work done before and there were no issues, all numbers were good. After the vaccine things were not. He does not have the results in front of him but knows that he has high calcium which they say may be due to dehydration, but he is drinking a ton of water. Also, he has high blood pressure and never did until this vaccine. The patient underwent lab tests and procedures which included blood pressure measurement was high, heart rate was heart rate gets very fast from just standing up, nerve conduction studies was unknown, reflex test was unknown. The outcome of events was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202100929968 similar report from same reporter
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood pressure measurement, Burning sensation, Cognitive disorder, Feeling abnormal, Headache
Clinical narrative: borderline paralyzed in his legs;; tingling in his hands and feet; extreme fatigue in arms and legs-; pins and needles in his feet; heart rate gets very fast from just standing up; His vision got blurry; sparks and burning feeling in his arms and legs; general mental fog, confusion, problems with depth perception and mental strain to remember; had nerve pain; a mild headache; After the first dose he was not feeling great; This is a spontaneous report from a contactable consumer or other non hcp. A 32-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0196, Expiration date was not reported), dose 1 via an unspecified route of administration on 12Jun2021 10:00 (age at vaccination 32 years) as dose 1, single for covid-19 immunisation. Medical history included guillain barre syndrome. There were no concomitant medications. On an unspecified date the patient experienced borderline paralyzed in his legs, tingling in his hands and feet, extreme fatigue in arms and legs, pins and needles in his feet, heart rate gets very fast from just standing up, his vision got blurry, sparks and burning feeling in his arms and legs, general mental fog, confusion, problems with depth perception and mental strain to remember, After the first dose he was not feeling great, had nerve pain, a mild headache. He has started nothing new, and he doesn't take anything not even take Advil for a headache. It showed reflex in knees and elbows, they don't work anymore. It was the same test they do for guillain barre syndrome. His primary care did blood work done and reflex tests and told him his reflexes were not good and they always have been. His blood pressure was high and had never been before. The caller states he had blood work done before and there were no issues, all numbers were good. After the vaccine things were not. He does not have the results in front of him but knows that he has high calcium which they say may be due to dehydration, but he is drinking a ton of water. Also, he has high blood pressure and never did until this vaccine. The patient underwent lab tests and procedures which included blood pressure measurement was high, heart rate was heart rate gets very fast from just standing up, nerve conduction studies was unknown, reflex test was unknown. The outcome of events was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202100929968 similar report from same reporter